CMPX
Price
$2.92
Change
-$0.16 (-5.19%)
Updated
Feb 21 closing price
Capitalization
402.45M
25 days until earnings call
CPRX
Price
$21.62
Change
-$0.43 (-1.95%)
Updated
Feb 21 closing price
Capitalization
2.58B
4 days until earnings call
Ad is loading...

CMPX vs CPRX

Header iconCMPX vs CPRX Comparison
Open Charts CMPX vs CPRXBanner chart's image
Compass Therapeutics
Price$2.92
Change-$0.16 (-5.19%)
Volume$1.13M
Capitalization402.45M
Catalyst Pharmaceuticals
Price$21.62
Change-$0.43 (-1.95%)
Volume$918.57K
Capitalization2.58B
CMPX vs CPRX Comparison Chart
Loading...
CMPX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CPRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CMPX vs. CPRX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CMPX is a Hold and CPRX is a Hold.

Ad is loading...
COMPARISON
Comparison
Feb 23, 2025
Stock price -- (CMPX: $2.92 vs. CPRX: $21.62)
Brand notoriety: CMPX and CPRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CMPX: 64% vs. CPRX: 80%
Market capitalization -- CMPX: $402.45M vs. CPRX: $2.58B
CMPX [@Biotechnology] is valued at $402.45M. CPRX’s [@Biotechnology] market capitalization is $2.58B. The market cap for tickers in the [@Biotechnology] industry ranges from $369.14B to $0. The average market capitalization across the [@Biotechnology] industry is $2.44B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CMPX’s FA Score shows that 0 FA rating(s) are green whileCPRX’s FA Score has 1 green FA rating(s).

  • CMPX’s FA Score: 0 green, 5 red.
  • CPRX’s FA Score: 1 green, 4 red.
According to our system of comparison, CPRX is a better buy in the long-term than CMPX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CMPX’s TA Score shows that 3 TA indicator(s) are bullish while CPRX’s TA Score has 5 bullish TA indicator(s).

  • CMPX’s TA Score: 3 bullish, 5 bearish.
  • CPRX’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, CPRX is a better buy in the short-term than CMPX.

Price Growth

CMPX (@Biotechnology) experienced а -13.61% price change this week, while CPRX (@Biotechnology) price change was -7.09% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.71%. For the same industry, the average monthly price growth was -2.01%, and the average quarterly price growth was +0.86%.

Reported Earning Dates

CMPX is expected to report earnings on May 12, 2025.

CPRX is expected to report earnings on May 07, 2025.

Industries' Descriptions

@Biotechnology (-1.71% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CPRX($2.58B) has a higher market cap than CMPX($402M). CMPX YTD gains are higher at: 101.379 vs. CPRX (3.594). CPRX has higher annual earnings (EBITDA): 211M vs. CMPX (-53.58M). CPRX has more cash in the bank: 442M vs. CMPX (135M). CPRX has less debt than CMPX: CPRX (3.28M) vs CMPX (6.88M). CPRX has higher revenues than CMPX: CPRX (460M) vs CMPX (850K).
CMPXCPRXCMPX / CPRX
Capitalization402M2.58B16%
EBITDA-53.58M211M-25%
Gain YTD101.3793.5942,821%
P/E RatioN/A18.32-
Revenue850K460M0%
Total Cash135M442M31%
Total Debt6.88M3.28M210%
FUNDAMENTALS RATINGS
CPRX: Fundamental Ratings
CPRX
OUTLOOK RATING
1..100
71
VALUATION
overvalued / fair valued / undervalued
1..100
66
Overvalued
PROFIT vs RISK RATING
1..100
16
SMR RATING
1..100
34
PRICE GROWTH RATING
1..100
46
P/E GROWTH RATING
1..100
84
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CMPXCPRX
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
78%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
72%
MACD
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
77%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
71%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
64%
Advances
ODDS (%)
Bullish Trend 17 days ago
86%
Bullish Trend 9 days ago
80%
Declines
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
68%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
73%
Bullish Trend 2 days ago
87%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
82%
View a ticker or compare two or three
Ad is loading...
CMPX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CPRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AMRAX6.62N/A
N/A
American Growth One A
TSOHX13.90N/A
N/A
Nuveen International Res Eq I
MFCAX37.87N/A
N/A
Meridian Contrarian A
RLISX23.98-0.27
-1.11%
Russell Inv Equity Income S
MITHX36.27-0.45
-1.23%
MFS Massachusetts Investors Tr R3

CMPX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CMPX has been loosely correlated with ARVN. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if CMPX jumps, then ARVN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CMPX
1D Price
Change %
CMPX100%
-5.19%
ARVN - CMPX
37%
Loosely correlated
-3.27%
VCYT - CMPX
37%
Loosely correlated
-4.56%
VIR - CMPX
36%
Loosely correlated
-2.35%
FHTX - CMPX
35%
Loosely correlated
-2.79%
ABOS - CMPX
35%
Loosely correlated
+0.72%
More

CPRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CPRX has been loosely correlated with SANA. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if CPRX jumps, then SANA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CPRX
1D Price
Change %
CPRX100%
-1.95%
SANA - CPRX
44%
Loosely correlated
-1.63%
ALDX - CPRX
37%
Loosely correlated
-0.45%
VIR - CPRX
37%
Loosely correlated
-2.35%
CDTX - CPRX
35%
Loosely correlated
-3.75%
KYMR - CPRX
34%
Loosely correlated
-1.63%
More